Spots Global Cancer Trial Database for Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening

Official Title: Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening

Study ID: NCT04798664

Conditions

Smoking Cessation

Interventions

Removal of Financial Barriers

Financial Incentives

Mobile Health Application

Study Description

Brief Summary: To compare the effectiveness of four interventions to promote sustained, biochemically confirmed smoking abstinence for 6 months among underserved smokers referred for lung cancer screening at four large U.S. health systems.

Detailed Description: We will conduct a 4-arm randomized trial comparing 4 interventions to promote sustained, biochemically confirmed smoking abstinence for 6 months among smokers in underserved demographic groups. The 3,200 participants to be enrolled will be current smokers who are Black, Hispanic, and/or have low socioeconomic status (defined as household income \<200% of the federal poverty line or a high school education or less) or rural residence who are referred for low-dose computed tomography (LDCT) screening at 4 large health systems. All adult patients with LDCT orders will be further screened for eligibility. Eligible patients will enroll with opt-out consent and complete the study using the NIH-funded Way to Health online research portal. The primary outcome will be biochemically confirmed, sustained abstinence from smoking tobacco for 6 months following participants' selected quit dates. Relapse rates will be tracked at 12 months.